The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Sumarokov A.B.
National Medical Research Centre of Cardiology
Chubykina U.V.
National Medical Research Center of Cardiology
Ezhov M.V.
National Medical Research Center of Cardiology
Rhabdomyolysis is a rare complication of statin therapy. Case report and literature review
Journal: Russian Cardiology Bulletin. 2022;17(1): 84‑92
Views: 70559
Downloaded: 681
To cite this article:
Sumarokov AB, Chubykina UV, Ezhov MV. Rhabdomyolysis is a rare complication of statin therapy. Case report and literature review. Russian Cardiology Bulletin.
2022;17(1):84‑92. (In Russ.)
https://doi.org/10.17116/Cardiobulletin20221701184
Statins are worldwide medicines for the treatment dyslipidemia accompanying cardiovascular diseases. These drugs are capable to improve cardiovascular prognosis. Serious side effects of statins requiring discontinuation of therapy are rare. Serious side effects of statins include statin-associated muscle symptoms and rhabdomyolysis. The last one is a rare and life-threatening complication. The authors present a patient with statin-induced rhabdomyolysis and modern literature review devoted to this issue.
Authors:
Sumarokov A.B.
National Medical Research Centre of Cardiology
Chubykina U.V.
National Medical Research Center of Cardiology
Ezhov M.V.
National Medical Research Center of Cardiology
Received:
21.01.2022
Accepted:
03.02.2022
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.